Gene Expression Signature-Based Prognostic Risk Score in Primary Central Nervous System Lymphoma Patients
Clinical Cancer Research, 08/21/2012
Kawaguchi A et al. – The authors have identified gene expression signatures that can accurately predict survival in patients with primary central nervous system lymphomas (PCNSLs). These predictive genes should be useful as molecular biomarkers and could provide novel targets for therapeutic interventions.
